HSPA5 and Alzheimer disease: Hoozemans et al. (2005) demonstrated that the expression of ER chaperone, BiP, and the activated, phosphorylated form of UPR sensor PERK, were significantly increased in the temporal cortex and hippocampus in AD patients compared to controls.